The inhibitory effect of soy protein isolate on atherosclerosis in mice does not require the presence of LDL receptors or alteration of plasma lipoproteins

Journal of Nutrition

Volumn 132, Issue 1, 2002, Pages 43-49

  Adams, M R ^a   Golden, D L ^a   Anthony, M S ^a   Register, T C ^a   Williams, J K ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Isoflavones; Lipoproteins; Mice; Soy protein

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; CASEIN; CHOLESTEROL; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE DERIVATIVE; LACTALBUMIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; SOYBEAN PROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HYPOCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIVER CELL; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTAKE; PROTEIN ISOLATION; SEX DIFFERENCE;

ANIMALIA; GLYCINE MAX;

EID: 0036140126     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/132.1.43     Document Type: Article

References (66)

1. Dietary protein, cholesterol and atherosclerosis: A review of the early history
2. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys
3. Soy protein, isoflavones and cardiovascular risk
4. Metaanalysis of the effects of soy protein intake on serum lipids
5. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic postmenopausal women
6. Low density lipoprotein receptor activity is modulated by soybean globulins in cell culture
7. 7S globulin from soybean is metabolized in human cell cultures by a specific uptake and degradation system
8. Soybean protein diet and plasma cholesterol: From therapy to molecular mechanisms
9. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice
10. Cholesterol-lowering activity of various undigested fractions of soybean protein in rats
11. Dietary protein and lipid metabolism: A multifunctional effect
12. Antihypercholesterolemic effect of undigested fraction of soybean protein in young female volunteers
13. Soy and cardiovascular disease: Cholesterol lowering and beyond
14. Isoflavone aglycone-rich extract without soy protein attenuates atherosclerosis development in cholesterol-fed rabbits
15. Soybean isoflavones and their metabolic products inhibit in vitro lipoprotein oxidation in serum
16. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance
17. Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys
18. 2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans
19. Dietary soy protein isolate, compared with casein, reduces atherosclerotic lesion area in apolipoprotein E-deficient mice
20. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: No accentuation by apolipoprotein(a)
21. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery
22. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a)
23. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
24. Lipoprotein separation and low density lipoprotein molecular weight determination using high performance gelfiltration chromatography
25. Enzymatic determination of total serum cholesterol
26. Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human apoB100-overexpressing transgenic mice
27. Protein measurement with the Folin phenol reagent
28. Genistein, daidzein and their beta-glycoside conjugates: Antitumor isoflavones in soybean foods from American and Asian diets
29. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys
30. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins
31. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women
32. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: A randomized controlled trial in humans
33. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy product supplements
34. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
35. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta
36. Steroid and phyto-estrogen binding to sheep uterine receptors in vitro
37. Differential effects of dietary daidzein and equol on human breast cancer MCF-7 cells
38. Estrogenic activity of flavonoids in mice. The importance of estrogen receptor distribution, metabolism and bioavailability
39. The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: Physiology of delivery modifies estrogenic activity
40. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako)
41. The variable metabolic response to dietary isoflavones in humans
42. Compositional changes in trypsin inhibitors, phytic acid, saponins and isoflavones related to soybean processing
43. Effects of dietary saponins on fecal bile acids and neutral sterols, plasma lipids, and lipoprotein turnover in the pig
44. A trial of the effects of soya-bean flour and soy-bean saponins on plasma lipids, faecal bile acids and neutral sterols in hypercholesterolemic men
45. The effect of dietary protein source and saponins on serum lipids and the excretion of bile acids and neutral sterols in rabbits
46. Protein-saponin interaction and its influence on blood lipids
47. The effect of estrogen and hormone replacement on blood vessel walls
48. Oral contraceptive treatment decreases arterial LDL degradation in female cynomolgus monkeys
49. Estrogen and progesterone replacement therapy reduces LDL accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys
50. Estradiol suppresses MCP-1 expression in vivo. Implications for atherosclerosis
51. Estrogen modulation of JE/monocyte chemoattractant protein-1 expression in murine macrophages
52. Estradiol-17 beta regulates the induction of VCAM-1 mRNA expression by interleukin-1 in human umbilical vein endothelial cells
53. Repression of the interleukin-6 promoter by estrogen is mediated by NF-κB and C/EBP-β
54. 17 β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens
55. Effects of 17 beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression
56. Modulation of endothelial cell expression of ICAM-1, E-selectin and VCAM-1 by beta-estradiol, progesterone, and dexamethasone
57. 17 β-Estradiol inhibits LDL oxidation and cholestryl ester formation in cultured macrophages
58. Protective effect of 17 beta-estradiol against the cytoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells
59. Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta
60. Soy isoflavones enhance vascular reactivity in atherosclerotic female macaques
61. Biology of atherosclerotic plaoue formation: Possible role of growth factors in lesion development and the potential impact of soy
62. Dietary soy isoflavones inhibit in vivo constrictor responses of coronary arteries to collagen-induced platelet activation
63. Dietary soy isoflavones inhibit activation of rat platelets
64. Tyrosine kinase inhibitors regulate serotonin uptake in platelets
65. Second report of the ad hoc committee on standards for nutritional studies
66. Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies